Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
KEGG_2021_Human,Synthesis and degradation of ketone bodies,2/10,0.0377002805890218,0.9999860793759676,0,0,7.707802547770701,25.26685304864961,BDH1;HMGCS1
KEGG_2021_Human,Collecting duct acid secretion,3/27,0.0519656875035104,0.9999860793759676,0,0,3.856858054226475,11.405391233948931,ATP6V0A4;ATP6V1E1;ATP6V1E2
KEGG_2021_Human,Other types of O-glycan biosynthesis,4/47,0.0599919892426272,0.9999860793759676,0,0,2.8719815736681773,8.080447209087874,POFUT2;GALNT3;C1GALT1;GALNT8
KEGG_2021_Human,Phenylalanine metabolism,2/17,0.0986909328601277,0.9999860793759676,0,0,4.109341825902336,9.51625847722689,PAH;GLYAT
KEGG_2021_Human,Pancreatic secretion,6/102,0.1030621599476819,0.9999860793759676,0,0,1.9304887820512824,4.386887067383465,CHRM3;CPA1;PLA2G10;RAC1;PLCB1;SLC26A3
KEGG_2021_Human,Mucin type O-glycan biosynthesis,3/36,0.1034463646066605,0.9999860793759676,0,0,2.80368276062056,6.360720733930199,GALNT3;C1GALT1;GALNT8
KEGG_2021_Human,One carbon pool by folate,2/20,0.1297590918847903,0.9999860793759676,0,0,3.4239207360226467,6.991905289456875,DHFR2;TYMS
KEGG_2021_Human,Renin-angiotensin system,2/23,0.1626993465888117,0.9999860793759676,0,0,2.9343342432514405,5.328314593945411,ACE2;ENPEP
KEGG_2021_Human,Rheumatoid arthritis,5/93,0.1697648113060883,0.9999860793759676,0,0,1.752909090909091,3.108506020680845,HLA-DPB1;ATP6V0A4;ATP6V1E1;ATP6V1E2;TNFSF13B
KEGG_2021_Human,Caffeine metabolism,1/6,0.1747465296493253,0.9999860793759676,0,0,6.157392686804451,10.74107129714167,CYP1A2
KEGG_2021_Human,"Phenylalanine, tyrosine and tryptophan biosynthesis",1/6,0.1747465296493253,0.9999860793759676,0,0,6.157392686804451,10.74107129714167,PAH
KEGG_2021_Human,Epithelial cell signaling in Helicobacter pylori infection,4/70,0.178797546791964,0.9999860793759676,0,0,1.868912769871236,3.217335457800739,ATP6V0A4;RAC1;ATP6V1E1;ATP6V1E2
KEGG_2021_Human,mRNA surveillance pathway,5/98,0.196597268580809,0.9999860793759676,0,0,1.658236559139785,2.6972842120005627,RBM8A;FIP1L1;UPF3B;UPF3A;PPP2R3B
KEGG_2021_Human,Folate biosynthesis,2/26,0.1969097982370713,0.9999860793759676,0,0,2.567144373673036,4.171634077421116,DHFR2;PAH
KEGG_2021_Human,Vibrio cholerae infection,3/50,0.2082645362108925,0.9999860793759676,0,0,1.967117988394584,3.086302290164576,ATP6V0A4;ATP6V1E1;ATP6V1E2
KEGG_2021_Human,Oxytocin signaling pathway,7/154,0.2130819730546788,0.9999860793759676,0,0,1.4693113200336314,2.27167040263386,CACNB1;GUCY1A2;OXTR;PLCB1;CAMK1G;PIK3R5;KCNJ3
KEGG_2021_Human,Metabolism of xenobiotics by cytochrome P450,4/76,0.2177055203657581,0.9999860793759676,0,0,1.712637557685481,2.61110769226945,GSTM3;CYP1A2;SULT2A1;GSTM5
KEGG_2021_Human,Butanoate metabolism,2/28,0.2201682295196481,0.9999860793759676,0,0,2.3694267515923566,3.5858035950282208,HMGCS1;BDH1
KEGG_2021_Human,Riboflavin metabolism,1/8,0.2259349405064763,0.9999860793759676,0,0,4.397683397683398,6.5415900931514495,ENPP1
KEGG_2021_Human,Synaptic vesicle cycle,4/78,0.2311541587508793,0.9999860793759676,0,0,1.6661773594680942,2.440400721448279,STX1B;ATP6V0A4;ATP6V1E1;ATP6V1E2
KEGG_2021_Human,Linoleic acid metabolism,2/29,0.2318827776016245,0.9999860793759676,0,0,2.2815522528898327,3.3345417868139715,CYP1A2;PLA2G10
KEGG_2021_Human,Glycosaminoglycan biosynthesis,3/53,0.2331931005567167,0.9999860793759676,0,0,1.848803827751196,2.6916520668364234,CSGALNACT1;CHSY3;HS6ST3
KEGG_2021_Human,SNARE interactions in vesicular transport,2/33,0.2789744161565503,0.9999860793759676,0,0,1.9867474830491063,2.5363517698333697,STX1B;STX4
KEGG_2021_Human,Cholinergic synapse,5/113,0.2842048355563732,0.9999860793759676,0,0,1.4268148148148148,1.7950187156102289,CHRM3;KCNQ4;PLCB1;PIK3R5;KCNJ3
KEGG_2021_Human,Nicotinate and nicotinamide metabolism,2/35,0.3024852212293148,0.9999860793759676,0,0,1.8661455317506277,2.231392868939359,ENPP1;NMNAT3
KEGG_2021_Human,Phospholipase D signaling pathway,6/148,0.3237593357255678,0.9999860793759676,0,0,1.3020043336944744,1.4683416762212362,RALA;SHC3;GRM7;SPHK1;PLCB1;PIK3R5
KEGG_2021_Human,Spliceosome,6/150,0.3349163226029124,0.9999860793759676,0,0,1.283787393162393,1.4043023719254808,PRPF6;RBM8A;SNRNP27;U2AF1;SF3B1;RNU4-2
KEGG_2021_Human,NOD-like receptor signaling pathway,7/181,0.3448451923039605,0.9999860793759676,0,0,1.2395712256231437,1.319721505170664,IFI16;STING1;TRPV2;TAB3;NLRP1;ANTXR2;PLCB1
KEGG_2021_Human,Aminoacyl-tRNA biosynthesis,3/66,0.3450383266536542,0.9999860793759676,0,0,1.4663173084225716,1.5603079199818048,SARS1;NARS1;TARS3
KEGG_2021_Human,Non-alcoholic fatty liver disease,6/155,0.3629786368184878,0.9999860793759676,0,0,1.2403846153846154,1.2570197833303642,IRS1;SDHC;RAC1;NDUFC2-KCTD14;ADIPOR2;MAP3K11
KEGG_2021_Human,Fc gamma R-mediated phagocytosis,4/97,0.3653938825112182,0.9999860793759676,0,0,1.3244700951595727,1.333449177358336,HCK;ACTR3C;SPHK1;RAC1
KEGG_2021_Human,Hematopoietic cell lineage,4/99,0.3797533105228269,0.9999860793759676,0,0,1.2964519926013116,1.2552681465413396,CD5;HLA-DPB1;CD9;CD44
KEGG_2021_Human,Transcriptional misregulation in cancer,7/192,0.4015278852170548,0.9999860793759676,0,0,1.1651989067719404,1.0632187122667622,CCNA2;LDB1;NFKBIZ;ETV4;PBX1;ETV5;RUNX1
KEGG_2021_Human,Oxidative phosphorylation,5/133,0.4088122745879667,0.9999860793759676,0,0,1.202625,1.0757471180103944,SDHC;ATP6V0A4;ATP6V1E1;NDUFC2-KCTD14;ATP6V1E2
KEGG_2021_Human,Basal transcription factors,2/45,0.4166337016942412,0.9999860793759676,0,0,1.431417567767738,1.2532745830974683,CCNH;GTF2F1
KEGG_2021_Human,Nitrogen metabolism,1/17,0.4197729536103766,0.9999860793759676,0,0,1.923092209856916,1.6693234628570062,CA9
KEGG_2021_Human,Selenocompound metabolism,1/17,0.4197729536103766,0.9999860793759676,0,0,1.923092209856916,1.6693234628570062,TXNRD2
KEGG_2021_Human,Wnt signaling pathway,6/166,0.4249275023618987,0.9999860793759676,0,0,1.1544471153846154,0.9880182179671506,FZD1;SFRP1;FRAT2;RAC1;PLCB1;RSPO4
KEGG_2021_Human,Hepatocellular carcinoma,6/168,0.4361327414143383,0.9999860793759676,0,0,1.1400759734093069,0.9460448806606964,FZD1;GSTM3;FRAT2;SHC3;TXNRD2;GSTM5
KEGG_2021_Human,Nucleotide excision repair,2/47,0.4383935783288459,0.9999860793759676,0,0,1.367657466383581,1.127822579571744,CCNH;XPC
KEGG_2021_Human,Bacterial invasion of epithelial cells,3/77,0.4389046863832403,0.9999860793759676,0,0,1.2476399844820898,1.0273978469051894,ACTR3C;SHC3;RAC1
KEGG_2021_Human,Tight junction,6/169,0.4417211378488047,0.9999860793759676,0,0,1.133022652194431,0.9257661897108804,CLDN4;ACTR3C;NEDD4;MARVELD3;RAC1;RUNX1
KEGG_2021_Human,Amino sugar and nucleotide sugar metabolism,2/48,0.4491063287529076,0.9999860793759676,0,0,1.3378565494322905,1.070948290493949,CYB5R2;CHIT1
KEGG_2021_Human,Intestinal immune network for IgA production,2/48,0.4491063287529076,0.9999860793759676,0,0,1.3378565494322905,1.070948290493949,HLA-DPB1;TNFSF13B
KEGG_2021_Human,Glycosaminoglycan degradation,1/19,0.4557824618146399,0.9999860793759676,0,0,1.709238650415121,1.3430165630817137,HGSNAT
KEGG_2021_Human,Cysteine and methionine metabolism,2/50,0.4701792296628884,0.9999860793759676,0,0,1.28197983014862,0.9674349477257296,LDHC;APIP
KEGG_2021_Human,Leukocyte transendothelial migration,4/114,0.4852261973679982,0.9999860793759676,0,0,1.1187917513796108,0.8090431906555738,CLDN4;TXK;ESAM;RAC1
KEGG_2021_Human,Pantothenate and CoA biosynthesis,1/21,0.4895605025740485,0.9999860793759676,0,0,1.5381558028616853,1.098623512097136,ENPP1
KEGG_2021_Human,Cell adhesion molecules,5/148,0.5007558466235048,0.9999860793759676,0,0,1.0756363636363635,0.7439495083289098,SELP;CLDN4;HLA-DPB1;ESAM;LRRC4C
KEGG_2021_Human,Terpenoid backbone biosynthesis,1/22,0.5056562106656004,0.9999860793759676,0,0,1.4648345824816411,0.998868162021364,HMGCS1
KEGG_2021_Human,Adrenergic signaling in cardiomyocytes,5/150,0.5126319216038407,0.9999860793759676,0,0,1.060689655172414,0.7087498503213909,CACNB1;TPM1;PPP2R3B;PLCB1;PIK3R5
KEGG_2021_Human,Shigellosis,8/246,0.5138574733478227,0.9999860793759676,0,0,1.033910670377476,0.6883873822884821,ACTR3C;STING1;TAB3;CGAS;U2AF1;RAC1;PLCB1;CD44
KEGG_2021_Human,Sphingolipid signaling pathway,4/119,0.5188493306819716,0.9999860793759676,0,0,1.0698708153910266,0.7019869036653009,SPHK1;PPP2R3B;RAC1;PLCB1
KEGG_2021_Human,Phagosome,5/152,0.524390698133248,0.9999860793759676,0,0,1.0461496598639457,0.6753087137459651,HLA-DPB1;ATP6V0A4;RAC1;ATP6V1E1;ATP6V1E2
KEGG_2021_Human,AMPK signaling pathway,4/120,0.5254505547635694,0.9999860793759676,0,0,1.0605927068414671,0.6824905423459079,CCNA2;IRS1;PPP2R3B;ADIPOR2
KEGG_2021_Human,Pyrimidine metabolism,2/56,0.530378055945595,0.9999860793759676,0,0,1.1391837697570182,0.7224307186980602,ENPP1;TYMS
KEGG_2021_Human,RNA transport,6/186,0.5343194561673119,0.9999860793759676,0,0,1.0251068376068375,0.6424973827144219,RBM8A;UPF3B;UPF3A;EIF3E;EIF2S2;RNU4-2
KEGG_2021_Human,Vitamin digestion and absorption,1/24,0.5363432541251327,0.9999860793759676,0,0,1.337319416603304,0.8331244850261063,SLC19A3
KEGG_2021_Human,Glutathione metabolism,2/57,0.5399491363927978,0.9999860793759676,0,0,1.118413433700058,0.6892562064004003,GSTM3;GSTM5
KEGG_2021_Human,Hypertrophic cardiomyopathy,3/90,0.5424367122741146,0.9999860793759676,0,0,1.060496067755596,0.6486883280012853,MYBPC3;CACNB1;TPM1
KEGG_2021_Human,Morphine addiction,3/91,0.5499413346834328,0.9999860793759676,0,0,1.0483906046107003,0.6268785264028065,GABRR1;PDE4C;KCNJ3
KEGG_2021_Human,alpha-Linolenic acid metabolism,1/25,0.550965951070147,0.9999860793759676,0,0,1.2815315315315314,0.7638982199444918,PLA2G10
KEGG_2021_Human,VEGF signaling pathway,2/59,0.5586827652248487,0.9999860793759676,0,0,1.079059112750028,0.6281995890714122,SPHK1;RAC1
KEGG_2021_Human,Salivary secretion,3/93,0.5647304406521079,0.9999860793759676,0,0,1.0249867091972356,0.5856843323655696,CHRM3;GUCY1A2;PLCB1
KEGG_2021_Human,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,1/26,0.5651281882662692,0.9999860793759676,0,0,1.2302066772655007,0.7020822620409561,PIGO
KEGG_2021_Human,Long-term depression,2/60,0.5678436088988102,0.9999860793759676,0,0,1.0603997364375135,0.6000900032373102,GUCY1A2;PLCB1
KEGG_2021_Human,Mineral absorption,2/60,0.5678436088988102,0.9999860793759676,0,0,1.0603997364375135,0.6000900032373102,SLC26A3;ATOX1
KEGG_2021_Human,Viral myocarditis,2/60,0.5678436088988102,0.9999860793759676,0,0,1.0603997364375135,0.6000900032373102,HLA-DPB1;RAC1
KEGG_2021_Human,Biosynthesis of unsaturated fatty acids,1/27,0.5788444428140808,0.9999860793759676,0,0,1.1828298887122417,0.6466785342742122,ACOT1
KEGG_2021_Human,Fatty acid elongation,1/27,0.5788444428140808,0.9999860793759676,0,0,1.1828298887122417,0.6466785342742122,ACOT1
KEGG_2021_Human,Purine metabolism,4/129,0.5827629772670428,0.9999860793759676,0,0,0.9837699680511182,0.5312109251448611,GUCY2C;GUCY1A2;PDE4C;ENPP1
KEGG_2021_Human,Dilated cardiomyopathy,3/96,0.5863485434686453,0.9999860793759676,0,0,0.991768276997479,0.5294464518736577,MYBPC3;CACNB1;TPM1
KEGG_2021_Human,Pathogenic Escherichia coli infection,6/197,0.5906428371313454,0.9999860793759676,0,0,0.9655155054369714,0.5083861846114486,CLDN4;ACTR3C;NCL;TAB3;NCKAP1L;RAC1
KEGG_2021_Human,Circadian entrainment,3/97,0.5934002832096678,0.9999860793759676,0,0,0.9811666496996844,0.5120572302369709,GUCY1A2;PLCB1;KCNJ3
KEGG_2021_Human,Cytosolic DNA-sensing pathway,2/63,0.594495875190589,0.9999860793759676,0,0,1.008092304479482,0.5242498353279951,STING1;CGAS
KEGG_2021_Human,FoxO signaling pathway,4/131,0.5949466862543112,0.9999860793759676,0,0,0.9681769012100324,0.50275827088873,PLK4;IRS1;SGK3;SGK2
KEGG_2021_Human,GnRH secretion,2/64,0.6031024058098997,0.9999860793759676,0,0,0.991781384836655,0.5015123765531884,PLCB1;KCNJ3
KEGG_2021_Human,Cortisol synthesis and secretion,2/65,0.61157013182345,0.9999860793759676,0,0,0.975988272166616,0.479918459958465,PLCB1;PBX1
KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,3/100,0.6140828751834064,0.9999860793759676,0,0,0.9506733093276772,0.4635724375904532,COL4A3;RAC1;PLCB1
KEGG_2021_Human,Epstein-Barr virus infection,6/202,0.6150357973575212,0.9999860793759676,0,0,0.9406397174254316,0.4572212679604578,SEM1;CCNA2;NEDD4;HLA-DPB1;RAC1;CD44
KEGG_2021_Human,Citrate cycle (TCA cycle),1/30,0.6174553517081137,0.9999860793759676,0,0,1.06030371141933,0.5112238631122152,SDHC
KEGG_2021_Human,Acute myeloid leukemia,2/67,0.6280900596844669,0.9999860793759676,0,0,0.945859872611465,0.4398926737245284,CCNA2;RUNX1
KEGG_2021_Human,Asthma,1/31,0.6295235700927648,0.9999860793759676,0,0,1.0249072602013778,0.4743188639922643,HLA-DPB1
KEGG_2021_Human,Protein digestion and absorption,3/103,0.6340456606311702,0.9999860793759676,0,0,0.9220095693779904,0.4200991913893623,ACE2;CPA1;COL4A3
KEGG_2021_Human,Neuroactive ligand-receptor interaction,10/341,0.6356533605892274,0.9999860793759676,0,0,0.927736088100575,0.4203589793418909,UTS2R;CHRM3;OXTR;NMB;GABRR1;P2RY10;CALCR;NPW;GRM7;TRHR
KEGG_2021_Human,Retinol metabolism,2/68,0.6361430121786438,0.9999860793759676,0,0,0.9314804091874156,0.4213382837427484,ALDH1A1;CYP1A2
KEGG_2021_Human,Adipocytokine signaling pathway,2/69,0.6440586454440402,0.9999860793759676,0,0,0.9175301834775168,0.4036816192130888,IRS1;ADIPOR2
KEGG_2021_Human,Renin secretion,2/69,0.6440586454440402,0.9999860793759676,0,0,0.9175301834775168,0.4036816192130888,GUCY1A2;PLCB1
KEGG_2021_Human,Ubiquitin mediated proteolysis,4/140,0.6470685807204393,0.9999860793759676,0,0,0.9036835181356888,0.393376139334514,HERC3;NEDD4;CBLC;UBE2J1
KEGG_2021_Human,Prolactin signaling pathway,2/70,0.6518376056519568,0.9999860793759676,0,0,0.9039902585237916,0.3868715075645775,SHC3;SOCS6
KEGG_2021_Human,Base excision repair,1/33,0.6525315568705745,0.9999860793759676,0,0,0.9607511923688394,0.4101406276679903,PARP2
KEGG_2021_Human,Fructose and mannose metabolism,1/33,0.6525315568705745,0.9999860793759676,0,0,0.9607511923688394,0.4101406276679903,ENOSF1
KEGG_2021_Human,Propanoate metabolism,1/34,0.6634948605875215,0.9999860793759676,0,0,0.9315893433540492,0.38216978212458,LDHC
KEGG_2021_Human,Drug metabolism,3/108,0.6656936124757603,0.9999860793759676,0,0,0.8778765094554568,0.3572305619520105,GSTM3;CYP1A2;GSTM5
KEGG_2021_Human,Salmonella infection,7/249,0.6723464779515598,0.9999860793759676,0,0,0.8881047451016808,0.3525611353427389,ACTR3C;RALA;AHNAK2;RAB9A;TAB3;NCKAP1L;RAC1
KEGG_2021_Human,Starch and sucrose metabolism,1/36,0.6843961814423474,0.9999860793759676,0,0,0.87826481944129,0.333054106184923,ENPP1
KEGG_2021_Human,Glioma,2/75,0.6887112479581077,0.9999860793759676,0,0,0.8418549864758748,0.3139556609141443,SHC3;CAMK1G
KEGG_2021_Human,Thyroid hormone synthesis,2/75,0.6887112479581077,0.9999860793759676,0,0,0.8418549864758748,0.3139556609141443,DUOX1;PLCB1
KEGG_2021_Human,Retrograde endocannabinoid signaling,4/148,0.6895156237471564,0.9999860793759676,0,0,0.8531238906638268,0.3171623901970172,GABRR1;PLCB1;NDUFC2-KCTD14;KCNJ3
KEGG_2021_Human,African trypanosomiasis,1/37,0.6943555855099336,0.9999860793759676,0,0,0.8538244126479421,0.3114504519714228,PLCB1
KEGG_2021_Human,Aldosterone-regulated sodium reabsorption,1/37,0.6943555855099336,0.9999860793759676,0,0,0.8538244126479421,0.3114504519714228,IRS1
KEGG_2021_Human,Serotonergic synapse,3/113,0.6953018271292395,0.9999860793759676,0,0,0.8377555458895172,0.3044481096320781,KCND2;PLCB1;KCNJ3
KEGG_2021_Human,Chronic myeloid leukemia,2/76,0.6956886393019938,0.9999860793759676,0,0,0.8304355310724737,0.3013260869246311,SHC3;RUNX1
KEGG_2021_Human,Gastric acid secretion,2/76,0.6956886393019938,0.9999860793759676,0,0,0.8304355310724737,0.3013260869246311,CHRM3;PLCB1
KEGG_2021_Human,Pancreatic cancer,2/76,0.6956886393019938,0.9999860793759676,0,0,0.8304355310724737,0.3013260869246311,RALA;RAC1
KEGG_2021_Human,Glutamatergic synapse,3/114,0.7009795411463127,0.9999860793759676,0,0,0.830165093322988,0.2949382132104666,GRM7;PLCB1;KCNJ3
KEGG_2021_Human,Allograft rejection,1/38,0.7040011853797491,0.9999860793759676,0,0,0.8307051089245048,0.291556924182724,HLA-DPB1
KEGG_2021_Human,mTOR signaling pathway,4/154,0.7188936433007759,0.9999860793759676,0,0,0.8187433439829606,0.2702195722539278,FZD1;IRS1;ATP6V1E1;ATP6V1E2
KEGG_2021_Human,Nicotine addiction,1/40,0.7223901509824721,0.9999860793759676,0,0,0.7880233174350821,0.2562572322400189,GABRR1
KEGG_2021_Human,Chemokine signaling pathway,5/192,0.726925264511579,0.9999860793759676,0,0,0.820663101604278,0.2617354014550901,HCK;SHC3;RAC1;PLCB1;PIK3R5
KEGG_2021_Human,"Growth hormone synthesis, secretion and action",3/119,0.7281619478869014,0.9999860793759676,0,0,0.7941758785678931,0.2519378431859853,SHC3;IRS1;PLCB1
KEGG_2021_Human,Neurotrophin signaling pathway,3/119,0.7281619478869014,0.9999860793759676,0,0,0.7941758785678931,0.2519378431859853,SHC3;IRS1;RAC1
KEGG_2021_Human,Bladder cancer,1/41,0.7311523406711105,0.9999860793759676,0,0,0.7682829888712241,0.2405750956395867,DAPK2
KEGG_2021_Human,Ferroptosis,1/41,0.7311523406711105,0.9999860793759676,0,0,0.7682829888712241,0.2405750956395867,MAP1LC3B2
KEGG_2021_Human,Homologous recombination,1/41,0.7311523406711105,0.9999860793759676,0,0,0.7682829888712241,0.2405750956395867,SEM1
KEGG_2021_Human,Graft-versus-host disease,1/42,0.7396383928704153,0.9999860793759676,0,0,0.7495056031641397,0.2260462958193444,HLA-DPB1
KEGG_2021_Human,Tryptophan metabolism,1/42,0.7396383928704153,0.9999860793759676,0,0,0.7495056031641397,0.2260462958193444,CYP1A2
KEGG_2021_Human,Fat digestion and absorption,1/43,0.7478569966370834,0.9999860793759676,0,0,0.7316223786812022,0.2125681267643915,PLA2G10
KEGG_2021_Human,Type I diabetes mellitus,1/43,0.7478569966370834,0.9999860793759676,0,0,0.7316223786812022,0.2125681267643915,HLA-DPB1
KEGG_2021_Human,Complement and coagulation cascades,2/85,0.7528014874684318,0.9999860793759676,0,0,0.7400429744455529,0.2101379517042901,CLU;KLKB1
KEGG_2021_Human,ErbB signaling pathway,2/85,0.7528014874684318,0.9999860793759676,0,0,0.7400429744455529,0.2101379517042901,SHC3;NRG1
KEGG_2021_Human,Platelet activation,3/124,0.7533692953274062,0.9999860793759676,0,0,0.7611609790818142,0.2155605908892735,GUCY1A2;PLCB1;PIK3R5
KEGG_2021_Human,Vasopressin-regulated water reabsorption,1/44,0.7558165679250703,0.9999860793759676,0,0,0.714570932081192,0.2000488252113664,STX4
KEGG_2021_Human,Colorectal cancer,2/86,0.758541676729452,0.9999860793759676,0,0,0.731195025781013,0.2020712552614935,RALA;RAC1
KEGG_2021_Human,Insulin secretion,2/86,0.758541676729452,0.9999860793759676,0,0,0.731195025781013,0.2020712552614935,CHRM3;PLCB1
KEGG_2021_Human,Taste transduction,2/86,0.758541676729452,0.9999860793759676,0,0,0.731195025781013,0.2020712552614935,CHRM3;PLCB1
KEGG_2021_Human,Glycosphingolipid biosynthesis,1/45,0.7635252582509281,0.9999860793759676,0,0,0.6982945512357277,0.1884062053279045,B3GALT4
KEGG_2021_Human,Cardiac muscle contraction,2/87,0.7641662473264187,0.9999860793759676,0,0,0.7225552641438742,0.1943456260104269,CACNB1;TPM1
KEGG_2021_Human,ECM-receptor interaction,2/88,0.7696767739008966,0.9999860793759676,0,0,0.714116427195971,0.1869447021131123,COL4A3;CD44
KEGG_2021_Human,Gap junction,2/88,0.7696767739008966,0.9999860793759676,0,0,0.714116427195971,0.1869447021131123,GUCY1A2;PLCB1
KEGG_2021_Human,Diabetic cardiomyopathy,5/203,0.7701542387175323,0.9999860793759676,0,0,0.7746262626262627,0.2023048605578443,IRS1;SDHC;RAC1;PLCB1;NDUFC2-KCTD14
KEGG_2021_Human,Proteasome,1/46,0.7709909631134553,0.9999860793759676,0,0,0.6827415650945062,0.1775664884917592,SEM1
KEGG_2021_Human,Type II diabetes mellitus,1/46,0.7709909631134553,0.9999860793759676,0,0,0.6827415650945062,0.1775664884917592,IRS1
KEGG_2021_Human,Calcium signaling pathway,6/240,0.7710918227666761,0.9999860793759676,0,0,0.7863247863247863,0.2044034115272059,CHRM3;OXTR;SPHK1;PLCB1;CAMK1G;TRHR
KEGG_2021_Human,cGMP-PKG signaling pathway,4/167,0.7753865647470536,0.9999860793759676,0,0,0.7529351810109959,0.1915418767796549,GUCY1A2;IRS1;PLCB1;PIK3R5
KEGG_2021_Human,Relaxin signaling pathway,3/129,0.7766636552362198,0.9999860793759676,0,0,0.7307663097136782,0.184699649057395,SHC3;COL4A3;PLCB1
KEGG_2021_Human,Carbohydrate digestion and absorption,1/47,0.7782213298311405,0.9999860793759676,0,0,0.6678647957420336,0.1674632971264853,PLCB1
KEGG_2021_Human,Pyruvate metabolism,1/47,0.7782213298311405,0.9999860793759676,0,0,0.6678647957420336,0.1674632971264853,LDHC
KEGG_2021_Human,"Valine, leucine and isoleucine degradation",1/48,0.7852237653221864,0.9999860793759676,0,0,0.6536210804045598,0.1580367863345826,HMGCS1
KEGG_2021_Human,Dopaminergic synapse,3/132,0.7897531804884815,0.9999860793759676,0,0,0.7136604725344016,0.1684487155370208,PPP2R3B;PLCB1;KCNJ3
KEGG_2021_Human,Ether lipid metabolism,1/49,0.7920054440186385,0.9999860793759676,0,0,0.6399708532061473,0.1492328919416644,PLA2G10
KEGG_2021_Human,Sphingolipid metabolism,1/49,0.7920054440186385,0.9999860793759676,0,0,0.6399708532061473,0.1492328919416644,SPHK1
KEGG_2021_Human,Vascular smooth muscle contraction,3/133,0.7939724763230445,0.9999860793759676,0,0,0.7081339712918661,0.1633710979503554,GUCY1A2;PLA2G10;PLCB1
KEGG_2021_Human,Cholesterol metabolism,1/50,0.7985733146022238,0.9999860793759676,0,0,0.6268777781382824,0.1410026784047174,VAPB
KEGG_2021_Human,Malaria,1/50,0.7985733146022238,0.9999860793759676,0,0,0.6268777781382824,0.1410026784047174,SELP
KEGG_2021_Human,Ovarian steroidogenesis,1/51,0.8049341074401343,0.9999860793759676,0,0,0.614308426073132,0.1333017703138784,ACOT1
KEGG_2021_Human,Staphylococcus aureus infection,2/95,0.8051921697201793,0.9999860793759676,0,0,0.660126018765838,0.1430323495653692,SELP;HLA-DPB1
KEGG_2021_Human,Endocytosis,6/252,0.8091439909949082,0.9999860793759676,0,0,0.7474984365228268,0.1583040164344117,ARF3;ACTR3C;NEDD4;PSD4;CBLC;EPN1
KEGG_2021_Human,Apelin signaling pathway,3/137,0.8101491024716656,0.9999860793759676,0,0,0.6868528172534457,0.1446079117568228,SPHK1;PLCB1;PIK3R5
KEGG_2021_Human,Estrogen signaling pathway,3/137,0.8101491024716656,0.9999860793759676,0,0,0.6868528172534457,0.1446079117568228,SHC3;PLCB1;KCNJ3
KEGG_2021_Human,Autoimmune thyroid disease,1/53,0.8170603307054352,0.9999860793759676,0,0,0.5906200317965024,0.1193302548435985,HLA-DPB1
KEGG_2021_Human,Endocrine and other factor-regulated calcium reabsorption,1/53,0.8170603307054352,0.9999860793759676,0,0,0.5906200317965024,0.1193302548435985,PLCB1
KEGG_2021_Human,Fluid shear stress and atherosclerosis,3/139,0.8178273505014731,0.9999860793759676,0,0,0.6766816774556713,0.136083410748219,GSTM3;RAC1;GSTM5
KEGG_2021_Human,Aldosterone synthesis and secretion,2/98,0.8188641861460512,0.9999860793759676,0,0,0.6393975583864119,0.1277753140200024,PLCB1;CAMK1G
KEGG_2021_Human,Inflammatory mediator regulation of TRP channels,2/98,0.8188641861460512,0.9999860793759676,0,0,0.6393975583864119,0.1277753140200024,TRPV2;PLCB1
KEGG_2021_Human,Pathways of neurodegeneration,12/475,0.8201517116959619,0.9999860793759676,0,0,0.7929291870242614,0.1572108518664736,FZD1;SEM1;CHRM3;UCHL1;FRAT2;TOMM40;VAPB;SDHC;RAC1;PLCB1;NDUFC2-KCTD14;UBE2J1
KEGG_2021_Human,Regulation of lipolysis in adipocytes,1/55,0.828433844165651,0.9999860793759676,0,0,0.5686863333922157,0.1070371723086583,IRS1
KEGG_2021_Human,Axon guidance,4/182,0.829013863078662,0.9999860793759676,0,0,0.688947122805758,0.1291902630725242,SEMA3C;RAC1;EFNA5;LRRC4C
KEGG_2021_Human,Melanogenesis,2/101,0.8316705198294632,0.9999860793759676,0,0,0.6199253683330116,0.1142639783478707,FZD1;PLCB1
KEGG_2021_Human,Amoebiasis,2/102,0.8357544806564817,0.9999860793759676,0,0,0.6136942675159236,0.1101092663257774,COL4A3;PLCB1
KEGG_2021_Human,Longevity regulating pathway,2/102,0.8357544806564817,0.9999860793759676,0,0,0.6136942675159236,0.1101092663257774,IRS1;ADIPOR2
KEGG_2021_Human,NF-kappa B signaling pathway,2/104,0.8436547872881104,0.9999860793759676,0,0,0.601598601223929,0.1022789139270601,TAB3;TNFSF13B
KEGG_2021_Human,Breast cancer,3/147,0.8459488584223387,0.9999860793759676,0,0,0.6388224348750664,0.1068726758604902,FZD1;FRAT2;SHC3
KEGG_2021_Human,Neutrophil extracellular trap formation,4/189,0.8501517534916262,0.9999860793759676,0,0,0.6626370779725412,0.1075727761871719,SELP;RAC1;PLCB1;H4C5
KEGG_2021_Human,"Parathyroid hormone synthesis, secretion and action",2/106,0.8512088172769984,0.9999860793759676,0,0,0.589968152866242,0.095042572561895,PDE4C;PLCB1
KEGG_2021_Human,Gastric cancer,3/149,0.8523626582168103,0.9999860793759676,0,0,0.6300058989316379,0.1006391504607144,FZD1;FRAT2;SHC3
KEGG_2021_Human,Glucagon signaling pathway,2/107,0.8548598879204837,0.9999860793759676,0,0,0.5843190779496512,0.0916315722641042,LDHC;PLCB1
KEGG_2021_Human,Th17 cell differentiation,2/107,0.8548598879204837,0.9999860793759676,0,0,0.5843190779496512,0.0916315722641042,HLA-DPB1;RUNX1
KEGG_2021_Human,Arachidonic acid metabolism,1/61,0.8584903998244054,0.9999860793759676,0,0,0.5116587175410705,0.0780687751747473,PLA2G10
KEGG_2021_Human,Steroid hormone biosynthesis,1/61,0.8584903998244054,0.9999860793759676,0,0,0.5116587175410705,0.0780687751747473,CYP1A2
KEGG_2021_Human,Coronavirus disease,5/232,0.8590042239444509,0.9999860793759676,0,0,0.6746431718061674,0.1025332405543647,SELP;ACE2;STING1;RPS27L;CGAS
KEGG_2021_Human,Ras signaling pathway,5/232,0.8590042239444509,0.9999860793759676,0,0,0.6746431718061674,0.1025332405543647,RALA;SHC3;PLA2G10;RAC1;EFNA5
KEGG_2021_Human,Basal cell carcinoma,1/63,0.8672916142837064,0.9999860793759676,0,0,0.4951023129391251,0.070492672316474,FZD1
KEGG_2021_Human,Lysine degradation,1/63,0.8672916142837064,0.9999860793759676,0,0,0.4951023129391251,0.070492672316474,KMT2B
KEGG_2021_Human,Cushing syndrome,3/155,0.8702256295689607,0.9999860793759676,0,0,0.604948375723999,0.0840894918416317,FZD1;PLCB1;PBX1
KEGG_2021_Human,Toxoplasmosis,2/112,0.8719169961154988,0.9999860793759676,0,0,0.5576143601621308,0.076427208329822,HLA-DPB1;PIK3R5
KEGG_2021_Human,PI3K-Akt signaling pathway,8/354,0.8725570062793573,0.9999860793759676,0,0,0.707172462502091,0.0964069056089316,IRS1;COL4A3;SGK3;PPP2R3B;RAC1;EFNA5;SGK2;PIK3R5
KEGG_2021_Human,Chemical carcinogenesis,5/239,0.8755366081651225,0.9999860793759676,0,0,0.6542222222222223,0.0869581148383598,GSTM3;PAQR7;CYP1A2;SULT2A1;GSTM5
KEGG_2021_Human,Inflammatory bowel disease,1/65,0.8755462418485692,0.9999860793759676,0,0,0.4795806836248013,0.0637397790708038,HLA-DPB1
KEGG_2021_Human,Glycolysis / Gluconeogenesis,1/67,0.8832881768285503,0.9999860793759676,0,0,0.4649997591174061,0.0577082234104433,LDHC
KEGG_2021_Human,Long-term potentiation,1/67,0.8832881768285503,0.9999860793759676,0,0,0.4649997591174061,0.0577082234104433,PLCB1
KEGG_2021_Human,Fc epsilon RI signaling pathway,1/68,0.8869768991683507,0.9999860793759676,0,0,0.4580357354720831,0.0549351300637327,RAC1
KEGG_2021_Human,Renal cell carcinoma,1/69,0.8905492149716365,0.9999860793759676,0,0,0.4512765360516225,0.0523105821143149,RAC1
KEGG_2021_Human,Hippo signaling pathway,3/163,0.8910618764833674,0.9999860793759676,0,0,0.5744617224880383,0.0662592238066341,FZD1;FAT4;AMH
KEGG_2021_Human,Central carbon metabolism in cancer,1/70,0.8940087920452182,0.9999860793759676,0,0,0.4447132554549434,0.0498255260987351,LDHC
KEGG_2021_Human,RIG-I-like receptor signaling pathway,1/70,0.8940087920452182,0.9999860793759676,0,0,0.4447132554549434,0.0498255260987351,STING1
KEGG_2021_Human,Parkinson disease,5/249,0.8962803999423913,0.9999860793759676,0,0,0.6270819672131147,0.0686667098836665,SEM1;UCHL1;SDHC;NDUFC2-KCTD14;UBE2J1
KEGG_2021_Human,Adherens junction,1/71,0.897359182838419,0.9999860793759676,0,0,0.4383374971610265,0.0474715434088032,RAC1
KEGG_2021_Human,Thyroid hormone signaling pathway,2/121,0.8980480413705991,0.9999860793759676,0,0,0.5152009848525397,0.0554004449172434,PLCB1;MED17
KEGG_2021_Human,Alzheimer disease,8/369,0.8985936617761615,0.9999860793759676,0,0,0.6772541439908792,0.0724149495234409,FZD1;SEM1;CHRM3;FRAT2;IRS1;SDHC;PLCB1;NDUFC2-KCTD14
KEGG_2021_Human,Human papillomavirus infection,7/331,0.9001664655181745,0.9999860793759676,0,0,0.6604938271604939,0.0694678154626348,FZD1;CCNA2;COL4A3;ATP6V0A4;PPP2R3B;ATP6V1E1;ATP6V1E2
KEGG_2021_Human,Rap1 signaling pathway,4/210,0.9007333871630276,0.9999860793759676,0,0,0.59443531126896,0.0621458179203255,RALA;RAC1;PLCB1;EFNA5
KEGG_2021_Human,Inositol phosphate metabolism,1/73,0.903746060043473,0.9999860793759676,0,0,0.4261172937643526,0.0431259954596643,PLCB1
KEGG_2021_Human,Cell cycle,2/124,0.9055934343966402,0.9999860793759676,0,0,0.502453795551843,0.0498257409796561,CCNA2;CCNH
KEGG_2021_Human,PPAR signaling pathway,1/74,0.9067891063992256,0.9999860793759676,0,0,0.4202582921358103,0.0411203296256929,HMGCS1
KEGG_2021_Human,Lipid and atherosclerosis,4/215,0.9102965993085232,0.9999860793759676,0,0,0.5801977499507897,0.0545297690659686,SELP;CASP6;RAC1;PLCB1
KEGG_2021_Human,Pathways in cancer,12/531,0.9116165212828312,0.9999860793759676,0,0,0.7052771386347906,0.0652634254223777,FZD1;CCNA2;GSTM3;RALA;FRAT2;TXNRD2;DAPK2;COL4A3;RAC1;PLCB1;GSTM5;RUNX1
KEGG_2021_Human,cAMP signaling pathway,4/216,0.9121080678499583,0.9999860793759676,0,0,0.577430827656881,0.0531217886419819,OXTR;PDE4C;RAC1;AMH
KEGG_2021_Human,Osteoclast differentiation,2/127,0.9126145098330928,0.9999860793759676,0,0,0.4903184713375796,0.044835560037702,CALCR;RAC1
KEGG_2021_Human,Lysosome,2/128,0.9148440281967214,0.9999860793759676,0,0,0.4864017793954099,0.0432905800077172,HGSNAT;ATP6V0A4
KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,1/77,0.915353902964866,0.9999860793759676,0,0,0.4036063927704794,0.0356967693548245,CACNB1
KEGG_2021_Human,Leishmaniasis,1/77,0.915353902964866,0.9999860793759676,0,0,0.4036063927704794,0.0356967693548245,HLA-DPB1
KEGG_2021_Human,Regulation of actin cytoskeleton,4/218,0.915633640411006,0.9999860793759676,0,0,0.5719745603296408,0.0504132372856296,CHRM3;ACTR3C;NCKAP1L;RAC1
KEGG_2021_Human,Antigen processing and presentation,1/78,0.9180304983779238,0.9999860793759676,0,0,0.3983441042264571,0.0340682465784147,HLA-DPB1
KEGG_2021_Human,Natural killer cell mediated cytotoxicity,2/131,0.9212164131398368,0.9999860793759676,0,0,0.4750160470053819,0.0389799565027019,SHC3;RAC1
KEGG_2021_Human,B cell receptor signaling pathway,1/81,0.9255638040520088,0.9999860793759676,0,0,0.3833465818759936,0.0296527050189336,RAC1
KEGG_2021_Human,Tuberculosis,3/180,0.9256872379122152,0.9999860793759676,0,0,0.5188278863568784,0.040063296583512,SPHK1;HLA-DPB1;ATP6V0A4
KEGG_2021_Human,Human cytomegalovirus infection,4/225,0.9269995505987424,0.9999860793759676,0,0,0.5536553279458748,0.0419682909075363,STING1;CGAS;RAC1;PLCB1
KEGG_2021_Human,Systemic lupus erythematosus,2/135,0.9290168297509368,0.9999860793759676,0,0,0.460634069249557,0.0339157607191396,HLA-DPB1;H4C5
KEGG_2021_Human,Autophagy,2/137,0.9326379310215752,0.9999860793759676,0,0,0.4537626798773295,0.0316446030027944,IRS1;DAPK2
KEGG_2021_Human,Insulin signaling pathway,2/137,0.9326379310215752,0.9999860793759676,0,0,0.4537626798773295,0.0316446030027944,SHC3;IRS1
KEGG_2021_Human,Yersinia infection,2/137,0.9326379310215752,0.9999860793759676,0,0,0.4537626798773295,0.0316446030027944,ACTR3C;RAC1
KEGG_2021_Human,Alcoholism,3/186,0.9352748710939084,0.9999860793759676,0,0,0.5016602609354982,0.0335685026089536,SHC3;SLC29A3;H4C5
KEGG_2021_Human,Apoptosis,2/142,0.9409409578955557,0.9999860793759676,0,0,0.4374431301182893,0.0266293003999711,CASP6;PARP2
KEGG_2021_Human,GABAergic synapse,1/89,0.9424420688628936,0.9999860793759676,0,0,0.3483523630582454,0.0206506161508624,GABRR1
KEGG_2021_Human,Spinocerebellar ataxia,2/143,0.9424806236701422,0.9999860793759676,0,0,0.4343181099516646,0.025728969354727,SEM1;PLCB1
KEGG_2021_Human,Amyotrophic lateral sclerosis,7/364,0.9430693645272245,0.9999860793759676,0,0,0.5984011582160954,0.0350755482391087,SEM1;TOMM40;VAPB;SDHC;NRG1;RAC1;NDUFC2-KCTD14
KEGG_2021_Human,Bile secretion,1/90,0.9442631816184212,0.9999860793759676,0,0,0.344420428359622,0.0197526347329521,SULT2A1
KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,3/193,0.9450129325868472,0.9999860793759676,0,0,0.4830017627801561,0.0273169695222598,HCK;RAC1;PIK3R5
KEGG_2021_Human,Small cell lung cancer,1/92,0.9477346222381742,0.9999860793759676,0,0,0.3368158074040427,0.0180805252422125,COL4A3
KEGG_2021_Human,Th1 and Th2 cell differentiation,1/92,0.9477346222381742,0.9999860793759676,0,0,0.3368158074040427,0.0180805252422125,HLA-DPB1
KEGG_2021_Human,GnRH signaling pathway,1/93,0.9493885225090476,0.9999860793759676,0,0,0.3331374853113983,0.0173022155904312,PLCB1
KEGG_2021_Human,IL-17 signaling pathway,1/94,0.9509901643559944,0.9999860793759676,0,0,0.3295382669196711,0.0165598116341848,TAB3
KEGG_2021_Human,TGF-beta signaling pathway,1/94,0.9509901643559944,0.9999860793759676,0,0,0.3295382669196711,0.0165598116341848,AMH
KEGG_2021_Human,Focal adhesion,3/201,0.9544690404668066,0.9999860793759676,0,0,0.4632932192740805,0.0215894972286936,SHC3;COL4A3;RAC1
KEGG_2021_Human,Phosphatidylinositol signaling system,1/97,0.9554977672190456,0.9999860793759676,0,0,0.3191905140434552,0.0145304625534675,PLCB1
KEGG_2021_Human,Prostate cancer,1/97,0.9554977672190456,0.9999860793759676,0,0,0.3191905140434552,0.0145304625534675,ETV5
KEGG_2021_Human,Viral carcinogenesis,3/203,0.9565834723975676,0.9999860793759676,0,0,0.4586124401913876,0.0203565337213093,CCNA2;RAC1;H4C5
KEGG_2021_Human,MAPK signaling pathway,5/294,0.9567282529597546,0.9999860793759676,0,0,0.5281937716262975,0.0233651189671076,DUSP4;CACNB1;RAC1;EFNA5;MAP3K11
KEGG_2021_Human,Choline metabolism in cancer,1/98,0.9569063504329852,0.9999860793759676,0,0,0.3158835002376542,0.0139145891369908,RAC1
KEGG_2021_Human,Glycerophospholipid metabolism,1/98,0.9569063504329852,0.9999860793759676,0,0,0.3158835002376542,0.0139145891369908,PLA2G10
KEGG_2021_Human,Proteoglycans in cancer,3/205,0.9586057432402688,0.9999860793759676,0,0,0.4540243498034014,0.0191940614495804,FZD1;RAC1;CD44
KEGG_2021_Human,Progesterone-mediated oocyte maturation,1/100,0.959591366420442,0.9999860793759676,0,0,0.3094698977051918,0.012764935462202,CCNA2
KEGG_2021_Human,Viral protein interaction with cytokine and cytokine receptor,1/100,0.959591366420442,0.9999860793759676,0,0,0.3094698977051918,0.012764935462202,IL20RB
KEGG_2021_Human,Hepatitis C,2/157,0.9604003853604014,0.9999860793759676,0,0,0.3948017259091843,0.0159519690198693,CLDN4;EIF3E
KEGG_2021_Human,Chagas disease,1/102,0.9621093276072532,0.9999860793759676,0,0,0.3033102992334209,0.0117160241365365,PLCB1
KEGG_2021_Human,T cell receptor signaling pathway,1/104,0.9644706119554236,0.9999860793759676,0,0,0.2973899084692917,0.0107583525919483,GRAP2
KEGG_2021_Human,Toll-like receptor signaling pathway,1/104,0.9644706119554236,0.9999860793759676,0,0,0.2973899084692917,0.0107583525919483,RAC1
KEGG_2021_Human,Human immunodeficiency virus 1 infection,3/212,0.9650092614793228,0.9999860793759676,0,0,0.438657539891486,0.0156239201518585,STING1;CGAS;RAC1
KEGG_2021_Human,JAK-STAT signaling pathway,2/162,0.9653939609117084,0.9999860793759676,0,0,0.3823646496815286,0.0134665049197381,IL20RB;SOCS6
KEGG_2021_Human,Insulin resistance,1/108,0.9687614843860236,0.9999860793759676,0,0,0.2862130959986925,0.0090835002453095,IRS1
KEGG_2021_Human,MicroRNAs in cancer,5/310,0.9688730698252191,0.9999860793759676,0,0,0.5000655737704918,0.0158129068338426,IRS1;TPM1;ZFPM2;EFNA5;CD44
KEGG_2021_Human,HIF-1 signaling pathway,1/109,0.96975076744668,0.9999860793759676,0,0,0.2835482541364894,0.0087095195746245,LDHC
KEGG_2021_Human,TNF signaling pathway,1/112,0.9725348341825056,0.9999860793759676,0,0,0.2758418195620103,0.0076820250100778,TAB3
KEGG_2021_Human,Prion disease,4/273,0.9743197716839532,0.9999860793759676,0,0,0.453721629036664,0.0118038955563529,SEM1;SDHC;RAC1;NDUFC2-KCTD14
KEGG_2021_Human,Cytokine-cytokine receptor interaction,4/295,0.9845013765145524,0.9999860793759676,0,0,0.4189365743333004,0.0065437820508114,IL20RB;INHA;AMH;TNFSF13B
KEGG_2021_Human,Huntington disease,4/306,0.9880225714796104,0.9999860793759676,0,0,0.4034445549372659,0.0048614003244134,SEM1;SDHC;PLCB1;NDUFC2-KCTD14
KEGG_2021_Human,Measles,1/139,0.9884886280314348,0.9999860793759676,0,0,0.2215617151678532,0.0025652727131172,RAB9A
KEGG_2021_Human,Signaling pathways regulating pluripotency of stem cells,1/143,0.989880963900032,0.9999860793759676,0,0,0.2152757562865268,0.0021894796388267,FZD1
KEGG_2021_Human,Human T-cell leukemia virus 1 infection,2/219,0.9928710672745744,0.9999860793759676,0,0,0.2810913146849041,0.0020110579681802,CCNA2;HLA-DPB1
KEGG_2021_Human,Cellular senescence,1/156,0.9933455126382628,0.9999860793759676,0,0,0.1970870301041079,0.0013158963308657,CCNA2
KEGG_2021_Human,Ribosome,1/158,0.9937611768283195,0.9999860793759676,0,0,0.1945561147509442,0.001217603364701,RPS27L
KEGG_2021_Human,Hepatitis B,1/162,0.9945163114833128,0.9999860793759676,0,0,0.1896829236982689,0.0010430245021483,CCNA2
KEGG_2021_Human,Thermogenesis,2/232,0.9950723348750312,0.9999860793759676,0,0,0.2650235391858211,0.0013091754962106,SDHC;NDUFC2-KCTD14
KEGG_2021_Human,Protein processing in endoplasmic reticulum,1/171,0.9958981625974888,0.9999860793759676,0,0,0.1795567193491068,0.0007380271378651008,UBE2J1
KEGG_2021_Human,Influenza A,1/172,0.9960283966872646,0.9999860793759676,0,0,0.1784973828317481,0.0007103323116190836,HLA-DPB1
KEGG_2021_Human,Herpes simplex virus 1 infection,4/498,0.99990721120188,0.9999860793759676,0,0,0.2441567176727762,2.2656059516282373e-05,STING1;HLA-DPB1;CGAS;ZNF300
KEGG_2021_Human,Olfactory transduction,2/440,0.9999860793759676,0.9999860793759676,0,0,0.1376552365994823,1.9162601325893456e-06,OR2L13;OR2H2
